News
Optinose announces first quarter 2024 financial results reporting date
Optinose, Inc.
Conference call and webcast to be held on May 14, 2024, at 10:00 a.m. ET
YARDLEY, Pa., May 10, 2024 (GLOBE NEWSWIRE) – Optinosis (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by otolaryngologists and allergy specialists, today announced that the company will release first quarter 2024 financial results and corporate updates prior to the market open on Tuesday, 14 May 2024.
Company will hold conference call
Members of the Company’s leadership team will host a conference call to discuss financial results and corporate updates. The conference call is scheduled to begin at 10:00 a.m. Eastern Time on Tuesday, May 14, 2024.
Participants will be able to access the conference call live via webcast by visiting the Investors section of the Optinose website at http://ir.optinose.com/event-calendar. To participate by phone, register in advance at this link. After registering, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a personal PIN that can be used to access the conference call. Additionally, a replay of the webcast will be available on the Company’s website for 60 days after the event.
About Optinose
Optinose is a global specialty pharmaceutical company focused on meeting the needs of patients served by otolaryngologists and allergy specialists. To learn more, visit www.optinose.com or follow us on X It is LinkedIn.
Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531
